about
Oncolytic virotherapy using herpes simplex virus: how far have we come?Ubiquitin in Influenza Virus Entry and Innate ImmunityhTERT extends the life of human fibroblasts without compromising type I interferon signaling.HIV-1 Vpr Protein Enhances Proteasomal Degradation of MCM10 DNA Replication Factor through the Cul4-DDB1[VprBP] E3 Ubiquitin Ligase to Induce G2/M Cell Cycle Arrest.The ORF61 Protein Encoded by Simian Varicella Virus and Varicella-Zoster Virus Inhibits NF-κB Signaling by Interfering with IκBα Degradation.Hypoxia Moderates γ(1)34.5-Deleted Herpes Simplex Virus Oncolytic Activity in Human Glioma Xenoline Primary Cultures.Herpes simplex virus 1 infection activates poly(ADP-ribose) polymerase and triggers the degradation of poly(ADP-ribose) glycohydrolase.Single-cell analysis of Daxx and ATRX-dependent transcriptional repressionSp100A promotes chromatin decondensation at a cytomegalovirus-promoter-regulated transcription siteHSV-1 ICP22: hijacking host nuclear functions to enhance viral infection.Insights into the function of tegument proteins from the varicella zoster virus.The essential role of guinea pig cytomegalovirus (GPCMV) IE1 and IE2 homologs in viral replication and IE1-mediated ND10 targeting.Analysis of the functional interchange between the IE1 and pp71 proteins of human cytomegalovirus and ICP0 of herpes simplex virus 1.Impact of Type I Interferon on the Safety and Immunogenicity of an Experimental Live-Attenuated Herpes Simplex Virus 1 Vaccine in Mice.Depletion of intracellular zinc inhibits the ubiquitin ligase activity of viral regulatory protein ICP0 and restricts herpes simplex virus 1 replication in cell culture.iPSC Neuronal Assay Identifies Amaryllidaceae Pharmacophore with Multiple Effects against Herpesvirus Infections.
P2860
Q26862461-785193F3-F4E9-46E5-8423-DBCDBC7622BAQ28077694-DF3EC466-BDAE-417F-AEB2-ABC8F3719230Q34614831-E63C060E-4AC0-4EE0-A4E3-4FED54A3D1F3Q35837172-F78EC143-4BDA-44FF-BC4B-B16DC833866CQ35913878-9CA71479-EE2D-4693-90BD-51A58F038FCCQ36061803-84D1CEFB-67AC-4628-9582-42726D1AF954Q36171886-565106BA-EBB5-46B7-B9F4-CFB1082FDA2BQ36580532-815A05AC-345A-4187-9FD8-67149CDBB7D0Q36803209-7E6FA6B5-1DBF-4F2A-8A03-5DF2B15ED0C3Q38086860-01876A92-7667-4E35-B2AA-FE8354F49921Q38553727-2EDC2D3B-1267-4496-8D4C-9872FB70B92CQ38716767-B2497FCE-A517-49F8-8042-E6535DEBCE8AQ38924032-CB3AADF9-9FC9-4548-8449-C0C3E2CF0C93Q38998931-3EF0DC69-6B4F-44BB-AB0D-F8A05C0BAF9DQ39406161-A8ACEAD4-500A-4CDF-B23A-00A733192E64Q40814812-D0EB9ECC-B116-4E97-BF93-501308673201
P2860
description
2011 nî lūn-bûn
@nan
2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
HSV-1 ICP0: paving the way for viral replication
@ast
HSV-1 ICP0: paving the way for viral replication
@en
HSV-1 ICP0: paving the way for viral replication
@nl
type
label
HSV-1 ICP0: paving the way for viral replication
@ast
HSV-1 ICP0: paving the way for viral replication
@en
HSV-1 ICP0: paving the way for viral replication
@nl
prefLabel
HSV-1 ICP0: paving the way for viral replication
@ast
HSV-1 ICP0: paving the way for viral replication
@en
HSV-1 ICP0: paving the way for viral replication
@nl
P2860
P3181
P356
P1433
P1476
HSV-1 ICP0: paving the way for viral replication
@en
P2093
David J Davido
Miles C Smith
P2860
P304
P3181
P356
10.2217/FVL.11.24
P407
P577
2011-04-01T00:00:00Z